Search the record
clear ✕
104 results
Hearing Hearings to examine building a resilient health care future with biotechnology.
senate Health Care Subcommittee · Aug 4, 2026 · Transcript · 36 transcript matches
MICHELLE ROZO ". Thank you. Chairman Young, Ranking Member Hassan, and members of the subcommittee, thank you for the opportunity to testify. It is an honor to appear before you on behalf of the National Security Commission on Emerging Biotechnology to discuss why biotech is a matter of U.S. national security. First, let me say, Chairman Young, it has been a pleasure to serve alongside you as vice chair of the commission. Your leadership helped produce recommendations that will strengthen America's biotechnology future. I have two messages for the committee today. First, let me say, Chairman Young, it has..."
Hearing Hearings to examine behind the label, focusing on foreign ownership and control in America's drug supply chain.
senate Aging (Special) Committee · Jul 15, 2026 · Transcript · 19 transcript matches
THE HONORABLE NAZAK NIKAKHTAR "and or the president needs to institute an IEPA-based executive order to close the gap as it pertains to foreign adversaries. Time is running out and these gaps remain wide open today, enabling predatory FDI to occur largely undetected. Third, we need to impose broader export controls on emerging and foundational biotechnologies, biomaterials, and related data that are exported to China for pharmaceutical manufacturing and"
Hearing Hearings to examine measuring what matters, focusing on science, standards, and strategic competition.
senate Space and Science · Jul 21, 2026 · Transcript · 18 transcript matches
BUDD, TED "According to a recent Congressional Research Service report, the PRC's goal is to build self-reliance in areas it currently relies on, the United States and Europe, by boosting advanced manufacturing with decisive breakthroughs in advanced materials, equipment, machine tools, and high-end instruments, and industrial applications of artificial intelligence and robotics. It also calls for building PRC leadership in strategic and emerging sectors and making other decisive breakthroughs in core areas such as biotechnology, semiconductors, and software. But don't be confused. The PRC's plan is not..."
Hearing Unleashing the Golden Age of Science: Examining the Priorities of the FY2027 Research and Technology Enterprise
house Science, Space, and Technology Committee · Jul 22, 2026 · Transcript · 8 transcript matches
BAIRD, JAMES R. "Thank you. Thank you, Mr. Chairman and Ranking Member and Director Cratchit. We appreciate you being here as well. My question deals with biotechnology. In 2025, in the action plan, the National Security Commission on Emerging Biotechnology warned us that China is deeply embedded in our biotechnology supply chains, and to that point where we are dangerously reliant on Chinese-based suppliers for chemicals, for medicines, and pharmaceuticals. So that's why I introduced the Bill HR-7936, the Bio-Industrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026, which would direct the..."
Hearing Full Committee Markup
house Science, Space, and Technology Committee · Jul 21, 2026 · Transcript · 7 transcript matches
LOFGREN, ZOE "Bioengineering Center, was a participant in that project. It's a dazzling feat that demonstrates the U.S.'s burgeoning capability in new forms of biotechnology and I personally believe it's going to be in competition for a Nobel Prize. The best way to build on this momentous innovation is to elevate our ability to measure the biological inputs that made this possible in the first place and ensure we can pursue this"
CRS Report
Agricultural Biotechnology: Overview, Regulation, and Selected Policy Issues
Reports · Mar 29, 2021
Agricultural biotechnology refers to a range of tools—including genetic engineering and some conventional breeding techniques—to genetically modify living plants, animals, microbes, and other...
CRS Report
USDA’s Regulation of Agricultural Biotechnology
InFocus · Mar 3, 2026
The U.S. Department of Agriculture (USDA) regulates certain organisms developed using genetic engineering (GE) under its authority to prevent the introduction and dissemination of plant pests. In May...
Hearing Member Day to examine S.297, to amend title XXVII of the Public Health Service Act to require group health plans and health insurance issuers...
senate Health, Education, Labor, and Pensions Committee · Mar 19, 2026 · Request transcript
Hearing Pursuing the Golden Age of Innovation: Strategic Priorities in Biotechnology
house Research and Technology Subcommittee · Jun 5, 2025 · Request transcript
Hearing Final Report of the National Security Commission for Emerging Biotechnology
house Cyber, Information Technologies, and Innovation Subcommittee · Apr 8, 2025 · Request transcript
Testimony MICHELLE ROZO
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
". Thank you. Chairman Young, Ranking Member Hassan, and members of the subcommittee, thank you for the opportunity to testify. It is an honor to appear before you on behalf of the National Security Commission on Emerging Biotechnology to discuss why biotech is a matter of U.S. national security. First, let me say, Chairman Young, it has been a pleasure to serve alongside you as vice chair of the commission. Your leadership helped produce recommendations that will strengthen America's..."
Testimony BAIRD, JAMES R.
Unleashing the Golden Age of Science: Examining the Priorities of the ...
house Science, Space, and Technology Committee · Jul 22, 2026
"Thank you. Thank you, Mr. Chairman and Ranking Member and Director Cratchit. We appreciate you being here as well. My question deals with biotechnology. In 2025, in the action plan, the National Security Commission on Emerging Biotechnology warned us that China is deeply embedded in our biotechnology supply chains, and to that point where we are dangerously reliant on Chinese-based suppliers for chemicals, for medicines, and pharmaceuticals. So that's why I introduced the Bill HR-7936, the..."
Witness Todd Young
National Security Commission on Emerging Biotechnology · 1 hearing
Witness Michelle Rozo
National Security Commission on Emerging Biotechnology · 1 hearing
Witness John Crowley
Biotechnology Innovation Organization · 1 hearing
Hearing Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
house Health Subcommittee · Jul 15, 2026 · Transcript · 4 transcript matches
DEGETTE, DIANA "on just how we can work with the agency to strengthen it so that we can get cures to patients quickly and safely as possible and maintain our leadership in biotechnology and medicine as we go through the 21st century. And I yield"
Hearing “Building an AI-Ready America: How AI Is Creating Opportunities Across America's Workforce”
house Education and Workforce Committee · Jul 24, 2026 · Transcript · 3 transcript matches
MR. AJIKUMAR PARAYIL "My name is Aji Parayil. I'm the founder and chief executive officer of Manus, a next-generation industrial biotechnology company focused on the advanced biomanufacturing of complex natural products used in food ingredients, agricultural chemicals, and essential"
Testimony ALAN D. PALKOWITZ
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"gap is why the Indiana Bioscience Research Institute exists. Over the past decade, Indiana has shown that translational success comes not from any single institution, but from a connected ecosystem. Universities, global life science companies, health systems, entrepreneurs, philanthropy investors, and government working together to reduce the barriers between discovery and commercialization. That is the blueprint for the national strategy I'm recommending today. For this committee,..."
Testimony ALAN D. PALKOWITZ
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"regional partnerships, industry, philanthropy, and private capital around six connected priorities. Building translational research infrastructure, creating a national network of regional biotechnology translation hubs, building the biotechnology workforce of the future, expanding domestic biomanufacturing capacity and supply chain"
Testimony HASSAN, MARGARET WOOD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"A quick question for Dr. Rozo. The National Security Commission on Emerging Biotechnology found that much of our biotechnology infrastructure, such as manufacturing facilities and labs, is not adequately protected. In the commission's report, you recommended that Congress take action to ensure that biotechnology infrastructure and data are covered under the definition of critical infrastructure. How would it strengthen homeland security for the U.S. government to designate biotechnology..."
Testimony SPEAKER_09
China’s Economic Espionage and Subnational Influence in the United Sta...
house Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party · Jun 25, 2026
"And we know that within that plan, they have two very high priorities of focus. One is aerospace, and the second one is biotechnology, One is aerospace, and the second one is biotechnology, because they did not meet their goals out of the 12-ish or so of those goals within Made in China 2025. And so that's where I would place"
Testimony SCOTT, RICK
Hearings to examine China's toll on older Americans' health, finances,...
senate Aging (Special) Committee · Jun 17, 2026
"which prohibited federal agencies and federally funded groups from utilizing biotechnology equipment and services from biotechnology companies of concern. For too long, Washington has treated all these issues as individual"
Testimony SPEAKER_04
Hearings to examine China's toll on older Americans' health, finances,...
senate Aging (Special) Committee · Jun 17, 2026
"Combined together with our reliance on pharmaceuticals, we are dangerously close to a possible supply disruption on medical devices and prescription drugs, and Washington has not yet connected those dots adequately, so we appreciate your legislation to address this. As part of the commission's efforts to look over the horizon, we held a series of hearings since 2024 that highlight aggressive activity to not only catch up to the U.S., but to overtake us. The National Security Commission on..."
CRS Report
National Security Commission on Emerging Biotechnology: Final Report and Options for Congress
Posts · Apr 17, 2025
Section 1091 of the National Defense Authorization Act for Fiscal Year 2022 (P.L. 117-81) established the National Security Commission on Emerging Biotechnology (NSCEB) as an independent commission...
Hearing Hearings to examine China's toll on older Americans' health, finances, and security.
senate Aging (Special) Committee · Jun 17, 2026 · Transcript · 2 transcript matches
SCOTT, RICK "which prohibited federal agencies and federally funded groups from utilizing biotechnology equipment and services from biotechnology companies of concern. For too long, Washington has treated all these issues as individual"
CRS Report
Gene-Edited Plants: Regulation and Issues for Congress
Resources · Nov 30, 2024
Plant biotechnology, which includes gene editing and genetic engineering, allows a more precise and efficient method for developing desirable traits in crops compared to conventional breeding, which...
Hearing China’s Economic Espionage and Subnational Influence in the United States
house Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party · Jun 25, 2026 · Transcript
SPEAKER_09 "And we know that within that plan, they have two very high priorities of focus. One is aerospace, and the second one is biotechnology, One is aerospace, and the second one is biotechnology, because they did not meet their goals out of the 12-ish or so of those goals within Made in China 2025. And so that's where I would place"
Hearing Hearings to examine the next 250, focusing on small businesses leading the way.
senate Small Business and Entrepreneurship Committee · Aug 5, 2026 · Transcript
YOUNG, TODD "STTR, programs through September 30, 2031. These programs help ensure entrepreneurs transform promising ideas into commercial products, strengthening partnerships among small businesses, research institutions, and the federal government. By reauthorizing these programs, we help ensure America remains the world leader in developing and commercializing critical and emerging technologies. Now, for decades, the SBIR and STTR programs have supported breakthroughs in fields ranging from biotechnology to advanced manufacturing to artificial intelligence and national security. As new technologies..."
Hearing Hearings to examine the nomination of Keith Sonderling, of Florida, to be Secretary of Labor.
senate Health, Education, Labor, and Pensions Committee · Jul 16, 2026 · Transcript
KEITH SONDERLING "increasing our shipbuilding capacity, and positioning the United States to lead in biotechnology, AI, and quantum computing. The Working Families Tax Cuts are delivering for American"
Hearing Lowering Health Care Costs for All Americans: An Examination of the Prescription Drug Supply Chain
house Health Subcommittee · Feb 11, 2026 · Request transcript
Witness: John Crowley, Biotechnology Innovation Organization
Testimony YOUNG, TODD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"And a big shout out to members of the staff who worked very hard on both sides of the Over the past decade, biotechnology has emerged as a pivotal technology. It's a pivotal, if I can say that, technology domain of the 21st"
Testimony YOUNG, TODD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"Indiana also leads the United States in biomanufacturing, serving as the nation's number one life sciences exporter in 2024. However, China's rise in biotechnology and the growing risks of antimicrobial resistance present new challenges to the United States. For more than a decade, Beijing has poured enormous resources into their biotech sector in a deliberate bid for global"
Testimony YOUNG, TODD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"And pharmaceutical supply chains are strategically weaponized. Just as we face the threat of China's rise in biotechnology, antimicrobial resistance, or AMR, has become a growing public health crisis in recent"
Testimony YOUNG, TODD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"And as policymakers, it's our responsibility to empower our innovators, whether through R&D incentives, partnering with allies to strengthen supply chains, or cutting red tape. Without an industrious, innovative, and self-sustaining domestic biotechnology sector, the United States will remain at risk. Both of relying on China for new life-saving therapies and basic drugs, and of being unprepared for the next public health crisis. So it's my hope that this hearing will explore ways we can ensure..."
Testimony HASSAN, MARGARET WOOD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"Well, thank you, Chairman Young, for not only your statement, but for the work that you have done with me to hold today's hearing, and for your staff who have worked so well along with mine to make sure that this hearing could come together. I also want to thank the witnesses who are here for testifying before the committee and sharing your perspectives on health care and biotechnology. As the Chair has noted, one major emerging threat in this area is a surge of so-called superbugs, which are..."
Testimony HASSAN, MARGARET WOOD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"This is a priority not just for the health of our people, but also for our national security. Because as we face the challenge of combating superbugs and defending against other outbreaks, our foreign adversaries are growing increasingly sophisticated in their own biotechnology. In the development of medications and treatments, China has quickly grown its capacity and is now one of the fastest drug development pipelines in the"
Testimony HASSAN, MARGARET WOOD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"Furthermore, much of our supply chain for medications and medical devices made in the U.S. depends on ingredients and materials that come from abroad. As we look ahead to the future of biotechnology in the United States, it's critical that we consider ways to diversify, secure, and onshore our supply chains. Finally, as we grow this important work at home, we also need to protect against the possibility that our adversaries will steal this research and leapfrog ahead of us. We know that foreign..."
Testimony YOUNG, TODD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"He is president and CEO of the Indiana Biosciences Research Institute. He has extensive experience in the biotechnology industry, including 28 years at Eli Lilly and Company, where he served as vice president of discovery, chemistry, research, and technologies. Our second witness, Dr. Michelle Rosso, is vice chair of the National Security Commission on Emerging Biotechnology. Our second witness, Dr. Michelle Rosso, is vice chair of the National Security Commission on Emerging"
Testimony ALAN D. PALKOWITZ
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"industry, I've reached one conclusion. America does not have an innovation deficit. It has a translation deficit. Our scientists are succeeding. However, our innovation system is not translating enough of their discoveries into medicines, new companies, manufacturing, and jobs. The gap is what many in biotechnology call the valley of death, promising discoveries that are too advanced for academic funding, too early for industry investment, and too risky for private capital. When federally..."
Testimony ALAN D. PALKOWITZ
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"technology or drug against drug. China is competing ecosystem against ecosystem. This Congress has recently taken an important step on the security half of that challenge through the Biosecure Act. That is necessary, but it is defense. What America needs now is offense, a strategy that builds our own translational capacity as deliberately as China is building its own. That is why I recommend establishing a national translational biotechnology initiative. Let me be clear about what it is not. It..."
Testimony ALAN D. PALKOWITZ
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"I describe each in detail in my written testimony. Let me leave you with one final thought. Maintaining America's leadership in biotechnology is not inevitable. It is a policy choice. If we bridge America's translation gap, we achieve three"
Testimony MICHELLE ROZO
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"Imagine American doctors forced to ration treatments because supply chains have been weaponized. Imagine policymakers forced to choose between national security priorities and the health of the American people. Those are choices we should never have to face, but unfortunately, that is where we are heading. China's growing biotech capacity increases its strategic options while our dependence risks constraining ours. The Commission laid out a plan to change this trajectory. 49 recommendations to..."
Testimony MICHELLE ROZO
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"economic, geopolitical, and national security advantages, and the Chinese Communist Party has made that bet deliberately. The question before us is whether the United States will act with the same urgency. This committee has a critical role to play. The policy levers under your jurisdiction, including Medicare and Medicaid, tax and trade policy, are essential to enabling U.S. biotech policy, are essential to enabling U.S. biotech leadership and addressing China's non-market practices. Our..."
Testimony VERA P. LUTHER
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"I'm an infectious diseases, or ID, physician at Dartmouth Health in New Hampshire and fellow of the Infectious Disease Society of America. Strengthening biotechnology innovation is critical to addressing threats such as antimicrobial resistance, or AMR. AMR is killing Americans, driving up health care costs, and eroding our ability to perform routine surgeries, organ transplants, cancer chemotherapy, and neonatal"
Testimony YOUNG, TODD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"Dr. Palkowitz, while serving as chair of the National Security Commission on Emerging Biotechnology, the commission explored ways to address, as you might expect, the valley of death that small to mid-sized biotech companies are faced with. It's a challenge that you alluded to. I know you've wrestled with"
Testimony HASSAN, MARGARET WOOD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"Especially if you've got somebody who, because of the advanced treatment, has a suppressed immune system and therefore are more likely to get the infection. What are the most pressing areas for innovation, Dr. Luther, in biotechnology that you need in order to improve clinical care? Thank"
Testimony VERA P. LUTHER
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"Shortages in terms of antibiotics, shortages in terms of the diagnostics. And so we really need to leverage biotechnology to ensure that our manufacturing of these antimicrobials and critical materials remains secure. Thank you for that"
Testimony HASSAN, MARGARET WOOD
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"Thank you. Dr. Palkowitz, small biotechnology companies face significant obstacles when developing new antibiotics. Antibiotic research involves costly early-stage scientific research as well as clinical trials that are more complex than other types of trials because of the urgent and life-threatening nature of infections. I've been working on draft legislation that would give biotechnology companies bigger tax incentives to develop new antibiotics and help patients who get superbug infections...."
Testimony CORTEZ MASTO, CATHERINE
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"And now we understand why they were doing it. They're doing it with biotechnology now. And if we are not careful, we are going to see that to them. And that is a national security issue. It's a health issue. It is so many things that we are talking about right now. So I appreciate this"
Testimony MICHELLE ROZO
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"And I can imagine that incident was alarming for your constituents and you as well. We laid out an agenda to both make sure that the U.S. can run faster in biotechnology as well as stop what we see as anti-competitive national security issues stemming from Chinese biotech. And so the 49 recommendations in our action plan aim to do both of those"
Testimony MICHELLE ROZO
Hearings to examine building a resilient health care future with biote...
senate Finance Committee · Aug 4, 2026
"So the commission recommends that the fund is supported with close to a billion dollars of funding and that that is split across a number of technology areas including biotechnology. So it'd be up to the fund manager how they would deploy the"
Testimony BABIN, BRIAN
Unleashing the Golden Age of Science: Examining the Priorities of the ...
house Science, Space, and Technology Committee · Jul 22, 2026
"today's discussion will include funding levels, indirect cost policies, uniform guidance, and the President's budget request. Those are important discussions, but funding alone is not a measurement of success. The real question is whether taxpayer dollars are being invested wisely and deliver results for the American people. This budget directs taxpayer dollars towards technologies that will decide the next century artificial intelligence, quantum advanced manufacturing, nuclear, and..."
Testimony ROSS, DEBORAH K.
Unleashing the Golden Age of Science: Examining the Priorities of the ...
house Science, Space, and Technology Committee · Jul 22, 2026
"specifically China, and specifically in the area of biotechnology. Sadly, what we've been hearing this morning has been confirming what we"
Testimony SPEAKER_15
Unleashing the Golden Age of Science: Examining the Priorities of the ...
house Science, Space, and Technology Committee · Jul 22, 2026
"essentially making the consequential decision that no matter what scientific domain you are pursuing research in, whether you are in material science or in chemistry or in biotechnology, artificial intelligence is an accelerant, which everyone should be using as they pursue their next scientific"
Testimony MCCORMICK, RICHARD
Unleashing the Golden Age of Science: Examining the Priorities of the ...
house Science, Space, and Technology Committee · Jul 22, 2026
"So I'm super concerned just considering that we have about a million students in our advanced educational system. Over a quarter million of those are from China, a direct competitor of ours, and they've been trying to push, and the President's actually talked about, getting it up to 600,000 students per year just from China alone, which very much concerns me. So I'll be looking more into that and what we're doing to protect ourselves from that. America's biotechnological leadership depends on..."
Testimony BEGICH, NICHOLAS J.
Unleashing the Golden Age of Science: Examining the Priorities of the ...
house Science, Space, and Technology Committee · Jul 22, 2026
"I completely agree with you. Shifting gears, the budget shifts resources away from legacy institutional funding models toward direct support for AI, quantum, and biotechnology research. Can you speak to how this restructuring strengthens America's position against Chinese Communist Party investment in these same"
Testimony YOUNG, TODD
Hearings to examine the next 250, focusing on small businesses leading...
senate Small Business and Entrepreneurship Committee · Aug 5, 2026
"STTR, programs through September 30, 2031. These programs help ensure entrepreneurs transform promising ideas into commercial products, strengthening partnerships among small businesses, research institutions, and the federal government. By reauthorizing these programs, we help ensure America remains the world leader in developing and commercializing critical and emerging technologies. Now, for decades, the SBIR and STTR programs have supported breakthroughs in fields ranging from biotechnology..."
Testimony MR. AJIKUMAR PARAYIL
“Building an AI-Ready America: How AI Is Creating Opportunities Across...
house Education and Workforce Committee · Jul 24, 2026
"My name is Aji Parayil. I'm the founder and chief executive officer of Manus, a next-generation industrial biotechnology company focused on the advanced biomanufacturing of complex natural products used in food ingredients, agricultural chemicals, and essential"
Testimony MR. AJIKUMAR PARAYIL
“Building an AI-Ready America: How AI Is Creating Opportunities Across...
house Education and Workforce Committee · Jul 24, 2026
"There is a multi-pronged effect coming here from what our company does is we create cell factories which can consume U.S. produced corn and make this product at a commercial scale. So this is most advanced biotechnological processes. There, the design engineering of that cell we call cell factory is very critical. That is America invented and innovated in this technology last 25 years with"
Testimony BUDD, TED
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"According to a recent Congressional Research Service report, the PRC's goal is to build self-reliance in areas it currently relies on, the United States and Europe, by boosting advanced manufacturing with decisive breakthroughs in advanced materials, equipment, machine tools, and high-end instruments, and industrial applications of artificial intelligence and robotics. It also calls for building PRC leadership in strategic and emerging sectors and making other decisive breakthroughs in core..."
Testimony BUDD, TED
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"Under the first Trump administration, Dr. Copan served as Undersecretary of Commerce for Standards and Technology and the 16th Director of NIST. Our second witness is Dr. Drew Endy, Director of Biostrategy and Leadership at the Hoover Institution at Stanford University. Dr. Endy has extensive experience in Dr. Indy has extensive experience in biosecurity and currently serves as the Defense Science Board's Emerging Biotechnology and National Security Task Force. Our third witness is Robert..."
Testimony DR. WALTER COPAN
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"engineering, and manufacturing workforce. China now leads the world in highly cited top-tier research publications and international priority patent families across critical technologies, including biotechnology, quantum information science and technology, robotics, semiconductors, and artificial intelligence. It has strengthened its own IP system and the protections to counter areas where the United States leads, while substantially increasing its influence in international standards...."
Testimony DREW ENDY
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"My wife has left academia to start a company that brews the ingredients going into Narcan and other essential medicines. I want to acknowledge the work of the National Security Commission on Emerging Biotechnology, chaired by Senator Young. The commission's work is the best work I've seen in this town on"
Testimony DREW ENDY
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"Thanks very much for the opportunity to testify today. I look forward to your questions. What I observe is China appears to be building national laboratory-scale facilities for the 21st century across all sciences, and in particular in biology and biotechnology. They're advantaged in that in starting such an effort, they're not burdened by a legacy"
Testimony DREW ENDY
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"And so that's the capacity I see being developed in Shenzhen and throughout China to scale the measurement and experimentation and prototyping and tinkering and translation of biotechnology solutions. And we just don't have anything like it, not in the United States, not in"
Testimony DREW ENDY
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"the technical standard for packet switching networks, had not been advanced and promulgated by ARPA and NSF? When we look at the future of biotechnology, biotechnology is not about only the organisms we know and in medicines and stuff like that. biotechnology is not about only the organisms we know and in medicines and stuff like that. Biotechnology is a bottom-up manufacturing platform that will reshape how we build the majority of inputs to our"
Testimony BALDWIN, TAMMY
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"it can achieve global dominance in that space if left unchecked. And we cannot let China achieve dominance in biotechnology, which is so critical to our public health, our economic strength, and national security. Wisconsin is a national leader in the biohealth industry due to our investments in strong research institutions, advanced manufacturing, workforce"
Testimony BALDWIN, TAMMY
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"which consists of a consortium led by BioForward that focuses on personalized medicine and advancing the adoption of the next generation of Theranostics. I will add that it was the Commerce Committee with Senator Young's leadership that passed the legislation that allowed a number of tech hubs to be identified throughout the country. Dr. Endi, this is sort of a complement to Senator Budd's last question of you. Can you expand on the dangers of losing our global leadership role in biotechnology..."
Testimony DREW ENDY
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"We're at risk of seeing a future where China hoovers up the genetic resources of the world, refactors them, repackages them, and makes them available as the content kit for the future of biotechnology. Now, the good news is it will get done, and we're going to need it. Those are the sorts of things that are at stake, and it's hard to overstate it. Because biotechnology is as diverse as biology"
Testimony HICKENLOOPER, JOHN W.
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"Anyway, so I guess I'll start with you, Dr. Endy, and just say that, as you guys have all said, that research in science and engineering technology is essential to advance our competitiveness in not just artificial intelligence, but all forms of biotechnology, all forms of"
Testimony YOUNG, TODD
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"Well, thank you, Chairman. Thanks to you and the ranking member for convening this panel. I want to thank our witnesses. It's good to see Dr. Endy and Dr. Atkinson again. I'm grateful for your work. As our panelists have testified, China has emerged as a competitor in artificial intelligence, biotechnology, and other, what we're calling emerging technologies, critical scientific fields. Today, scientific data is often generated across different labs, research institutions, and companies using..."
Testimony BLUNT ROCHESTER, LISA
Hearings to examine measuring what matters, focusing on science, stand...
senate Commerce, Science, and Transportation Committee · Jul 21, 2026
"And so the notion of making sure we build the workforce, that we have the pipeline is really important to me. I also want to shift, Dr. Indy, Delaware is also home to a world-class biopharmaceutical industry and our University of Delaware's National Institute for Innovation in Manufacturing Biopharmaceuticals, also known as NIMBL, is there. So I'm particularly interested in the technologies that will shape the future of biotechnology and biomanufacturing. From your perspective, what advances in..."
Testimony LOFGREN, ZOE
Full Committee Markup
house Science, Space, and Technology Committee · Jul 21, 2026
"Bioengineering Center, was a participant in that project. It's a dazzling feat that demonstrates the U.S.'s burgeoning capability in new forms of biotechnology and I personally believe it's going to be in competition for a Nobel Prize. The best way to build on this momentous innovation is to elevate our ability to measure the biological inputs that made this possible in the first place and ensure we can pursue this"
Testimony MCCLAIN DELANEY, APRIL
Full Committee Markup
house Science, Space, and Technology Committee · Jul 21, 2026
"Today we'll be considering my bill, H.R. 8981, the Standards and Calibration for American I'm proud to have partnered on this legislation with Ranking Member Lofgren, Congressman Abernolte, and Delegate Moylan to help unlock the promises of biotechnology as it grows and expands across many industries. As my colleagues certainly know, I'm proud to represent Maryland's 6th District, home to the Gaithersburg campus of NIST, the National Institute of Standards and Technology. And NIST experts,..."
Testimony MCCLAIN DELANEY, APRIL
Full Committee Markup
house Science, Space, and Technology Committee · Jul 21, 2026
"critical legislation that is coming up for consideration this morning. As we learned in our hearing last year on the National Security Commission on Emerging Biotech Seminal Report and their recommendations to Congress, biotechnology stands at a very critical juncture. The policies that we advance today will shape the next century of scientific discoveries and determine whether the U.S. can keep its competitive edge. Most of us never think about weights and measurements, and that's exactly the..."
Testimony MCCLAIN DELANEY, APRIL
Full Committee Markup
house Science, Space, and Technology Committee · Jul 21, 2026
"we don't often wonder whether the number displayed is telling the truth about how many gallons we're putting in the tank. We have the trust because we have a system of standards. The same is true when we buy a pound of produce at the store, catch a flight timed to the very minute, or check a stock price down to the second. We rely on uniform standards to be in nearly everything we do, precisely because we don't have to think about them and because they build trust in everyday life. Today,..."
Testimony KEITH SONDERLING
Hearings to examine the nomination of Keith Sonderling, of Florida, to...
senate Health, Education, Labor, and Pensions Committee · Jul 16, 2026
"increasing our shipbuilding capacity, and positioning the United States to lead in biotechnology, AI, and quantum computing. The Working Families Tax Cuts are delivering for American"
Testimony DEGETTE, DIANA
Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role ...
house Energy and Commerce Committee · Jul 15, 2026
"on just how we can work with the agency to strengthen it so that we can get cures to patients quickly and safely as possible and maintain our leadership in biotechnology and medicine as we go through the 21st century. And I yield"
Testimony GUTHRIE, BRETT
Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role ...
house Energy and Commerce Committee · Jul 15, 2026
"Other countries, particularly China, are making significant investments to attract biotechnology companies, their clinical trials, and domestic manufacturing. Our ability to develop and manufacture life-saving medicines, vaccines, and other medical products here in the U.S. depends on a strong domestic biotechnology sector and a regulatory environment that supports"
Testimony MR. THOMAS BOLLYKY
Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role ...
house Energy and Commerce Committee · Jul 15, 2026
"The agency has lost real experience and expertise. Adding a user fee to enhance the number and quality of GCP inspections for IND submissions inspections for IND submissions with foreign clinical trial data would help boost FDA's inspection capacity. In conclusion, the same dynamic that hollowed out U.S. generic drug manufacturing is now playing out in biotechnology, but at an earlier stage when FDA and congressional intervention would be effective and is thus more urgent. The time to act is..."
Testimony THE HONORABLE NAZAK NIKAKHTAR
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"and or the president needs to institute an IEPA-based executive order to close the gap as it pertains to foreign adversaries. Time is running out and these gaps remain wide open today, enabling predatory FDI to occur largely undetected. Third, we need to impose broader export controls on emerging and foundational biotechnologies, biomaterials, and related data that are exported to China for pharmaceutical manufacturing and"
Testimony STEPHEN EZELL
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"And there's another unfair strategy, intentional Chinese obscuration about the true ownership nature or CCP or PLA links of Chinese companies servicing the US pharmaceutical supply chain. Recent ITF reports have documented such Chinese false flagging or brand obfuscation in sectors from aerospace to clean energy to biotechnology, as China directs its companies to downplay the company's home country identity when they operate in the United States. ITF's written testimony provided several case..."
Testimony SCOTT, RICK
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"He represented the United States at the United Nations Biological Weapons Convention and has been featured on CBS' 60 Minutes. For his work protecting U.S. biotechnology, he now runs EHY Consulting, LLC. Thanks for being here. Please begin your"
Testimony EDWARD YOU
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"I appreciate the title of today's hearing, looking at behind the label. I'm going to ask you to look beyond the label. And what I mean by that is an acknowledgment that biotechnology has become so advanced. In my 20 years in the FBI, now currently in my consultancy, you heard disparate technologies being laid out. What I'm witnessing and we should be acknowledging is that there's an absolute convergence of these technologies happening. And what this is translated into is that biotechnology is..."
Testimony EDWARD YOU
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"So the issue here is that unless we understand what the implications are, my recommendations are one, is understanding that it is absolutely strategic in nature that we are in the midst of this global biotech space race. Second is I recommend looking at the National Security Commission on Emerging Biotechnology that is supporting Congress. And a lot of their legislative recommendations address everything I just mentioned. Third, we absolutely need to do a better job in assessing the risks..."
Testimony DR. RUSH DOSHI
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"We then became dependent on China for essential medicines. Now we're making the same mistake again in biotechnology and none of this is good for our patients. My testimony draws from a year-long study we published last month at the Council on Foreign Relations. But my limited time today, I want to focus on just three priorities from that report. The second is our biotechnology innovation"
Testimony STEPHEN EZELL
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"It's identified rare earth magnets at critical areas it can get leverage. And there's no question that biotechnology, KSMs, and the APIs are special choke points that they could use to weaponize against the United States at their time of choosing, should we not have an ability to respond to that contingency. I'll answer that but also if I may add to Nizak's comment, is there a whole range of technologies that we invented in American labs and universities that are now manufactured, scaled, and..."
Testimony EDWARD YOU
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"They are dealing with environmental remediation challenges. Biotechnology offers that to them. So you see the full court press and from the whole scope in either funding and research and development, acquiring talent development, right? So we've seen that happen right now, too, looking at the talent going overseas. As was mentioned before, looking at investments that may not necessarily trip the bar, but then also looking at downstream, too, as I mentioned, the standards aspect of it as well is..."
Testimony GILLIBRAND, KIRSTEN E.
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"You may begin. The biotechnology space race is likely to define this century and the United States' continued lack of strategic investment risks seeding our competitive edge in global development. The National Security Commission on Emerging Biotechnologies 2025 report cautioned that the U.S. is dangerously close to falling behind China and urged immediate action to scale Mr. Yu, if the United States falls, if the United States fails to maintain global leadership in biotechnology, in what ways..."
Testimony EDWARD YOU
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"launched the Sputnik satellite, that was a wake-up call moment. One of the things that Congress did was pass the National Defense Education Act, which dropped billions of dollars from K-12 to college education to make sure that it shored up our workforce, the future computer scientists, engineers, physicists, to make sure that we maintain our advantage. If we acknowledge that this is a space race, we need bold moves like that to be able to counter it, because otherwise, that nightmare scenario..."
Testimony EDWARD YOU
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"recommendations. There is that. But quite frankly, too, that one of the challenges that I faced personally during my time in the Bureau, and it still exists today, and I just touched on in my recommendations, is that we need to do a better job in doing the risk assessments. Because if the intelligence community is forecasting biotechnology, and if the resulting products that are provided to you, the decision makers, is looking at pandemic preparedness or a bioweapon, those are important, yes...."
Testimony GILLIBRAND, KIRSTEN E.
Hearings to examine behind the label, focusing on foreign ownership an...
senate Aging (Special) Committee · Jul 15, 2026
"Yes. You previously discussed developing a bioeconomic strategy to ensure the U.S. retained its global competitive edge. What should the pillars of this proposal be, and what agency or coordinating body should be charged with implementing such a proposal? Yeah. Dr. Doshi, what advantages does China have over the U.S. in biotechnology development? How did they gain these advantages, and what steps should the U.S. take to regain them? And if you have any recommendations on the last two questions,..."
CRS Report
Gene-Edited Plants: Regulation and Issues for Congress
Reports · Sep 7, 2023
Throughout history, farmers and plant breeders have employed selective breeding techniques to develop desirable traits in crops. This has involved crossing plants with desired characteristics and...
CRS Report
Synthetic/Engineering Biology: Issues for Congress
Reports · Sep 30, 2022
Synthetic biology, sometimes referred to as engineering biology, is the application of engineering principles and the use of systematic design tools to enable the reprogramming of cellular systems at...
CRS Report
Advanced Gene Editing: CRISPR-Cas9
Reports · Dec 7, 2018
Scientists have long sought the ability to control and modify DNA—the code of life. A gene editing technology known as CRISPR-Cas9 offers the potential for substantial improvement over other gene...
CRS Report
Defense Primer: Emerging Technologies
InFocus · Jan 6, 2026
Senior U.S. defense and intelligence officials have identified a number of emerging technologies that could have a disruptive impact on U.S. national security in the years to come. These technologies...
CRS Report
The Bioeconomy: A Primer
Reports · Sep 19, 2022
The term bioeconomy refers to the share of the economy based on products, services, and processes derived from biological resources (e.g., plants and microorganisms). The bioeconomy is crosscutting,...
CRS Report
Science and Technology Issues for the 118th Congress
Reports · Oct 15, 2024
The federal government supports scientific and technological advancement directly by funding and performing research and development (R&D) and indirectly by creating and maintaining policies that...
CRS Report
The U.S.-Mexico Genetically Engineered Corn Dispute
Reports · Jun 5, 2024
In August 2023, the United States requested a dispute settlement panel under the United States-Mexico-Canada Agreement (USMCA) concerning Mexico’s February 2023 presidential decree banning...
CRS Report
Emerging Military Technologies: Background and Issues for Congress
Reports · Feb 22, 2024
Members of Congress and Pentagon officials are increasingly focused on developing emerging military technologies to enhance U.S. national security and keep pace with U.S. competitors. The U.S....
CRS Report
The National Bioengineered Food Disclosure Standard: Overview and Selected Considerations
Reports · Feb 7, 2020
/ In July 2016, Congress enacted P.L. 114-216 (2016 Act), comprehensive legislation to govern the labeling of bioengineered foods. The 2016 Act required the U.S. Department of Agriculture (USDA) to...
CRS Report
Patent-Eligible Subject Matter Reform: An Overview
InFocus · Jan 16, 2026
The U.S. patent system is designed to encourage innovation. The types of inventions that can be patented may affect the patent system’s ability to promote innovation in certain fields, especially in...
CRS Report
White House Initiative to Advance the Bioeconomy, E.O. 14081: In Brief
Reports · Oct 5, 2022
The bioeconomy is the portion of the economy based on products, services, and processes derived from biological resources (e.g., plants and microorganisms). According to the McKinsey Global...
Committee Conservation, Research, and Biotechnology Subcommittee
house Agriculture Committee